Vanda Pharmaceuticals Inc (VNDA)
Healthcare
Biotechnology
5.10 $
-1.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Vanda Pharmaceuticals Inc (VNDA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 89.5% of the shares are freely tradable; institutional investors hold 78.3%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
78.3%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
6.6%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
89.5%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
12.2%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
60Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 12.10 | 7,275,988 | -6.4 | 03/31/2026 |
| Renaissance Technologies Corp | 6.25 | 3,759,559 | +11.2 | 03/31/2026 |
| Vanguard Group Inc | 6.21 | 3,731,851 | +4.0 | 12/31/2025 |
| State Street Corp | 5.01 | 3,015,562 | +138.7 | 03/31/2026 |
| AIGH Capital Management, LLC | 4.57 | 2,750,000 | +37.6 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.13 | 2,481,491 | +0.0 | 03/31/2026 |
| Millennium Management LLC | 3.13 | 1,881,001 | +12.0 | 03/31/2026 |
| Acadian Asset Management LLC | 2.99 | 1,795,592 | +2,784.3 | 03/31/2026 |
| Dimensional Fund Advisors, Inc. | 2.95 | 1,771,593 | -16.4 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 3.16 | 1,897,886 | -0.6 | 05/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.